Brazil's health regulator Anvisa authorized on Friday the government biomedical institute Fiocruz to produce domestically the active ingredient for the AstraZeneca vaccine against COVID-19, according to a statement.
Brazil authorizes production of active ingredient for AstraZeneca vaccine
